| 标题 |
Efficacy and safety of sulbactam–durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii–calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK) |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Infectious Diseases 作者:Keith S. Kaye; Andrew F. Shorr; Richard G. Wunderink; Bin Du; Gabrielle Poirier; et al 出版日期:2023-05-11 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)